StonvexLoading…
StonvexStonvexStonvexCore line items from BHST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $34.51M | $25.19M | $12.67M |
Operating Income | $-5.58M | $-6.99M | $-9.97M |
Net Income | $-11.13M | $-12.91M | $-12.56M |
EPS (Diluted) | $-0.60 | $-0.80 | $-0.93 |
Total Assets | $47.66M | $25.00M | $15.00M |
Total Liabilities | Not available | Not available | Not available |
Cash & Equivalents | $23.02M | $2.39M | $5.36M |
Free Cash Flow OCF − CapEx | $-9.58M | $-9.52M | $-10.00M |
Shares Outstanding | Not available | Not available | Not available |